APA način citiranja

Puri, A., Niewiarowski, A., Arai, Y., Nomura, H., Baird, M., Dalrymple, I., . . . Boyce, M. (2017). Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab/Humira, in healthy subjects. Br J Clin Pharmacol.

Čikaški stil citiranja

Puri, Adeep, Andrew Niewiarowski, Yasumasa Arai, Hideaki Nomura, Mark Baird, Isobel Dalrymple, Steve Warrington, i Malcolm Boyce. "Pharmacokinetics, Safety, Tolerability and Immunogenicity of FKB327, a New Biosimilar Medicine of Adalimumab/Humira, in Healthy Subjects." Br J Clin Pharmacol 2017.

MLA način citiranja

Puri, Adeep, et al. "Pharmacokinetics, Safety, Tolerability and Immunogenicity of FKB327, a New Biosimilar Medicine of Adalimumab/Humira, in Healthy Subjects." Br J Clin Pharmacol 2017.